<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T07:08:26Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:10256/18590" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:10256/18590</identifier><datestamp>2024-06-18T12:37:46Z</datestamp><setSpec>com_2072_452955</setSpec><setSpec>com_2072_2054</setSpec><setSpec>col_2072_453068</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Insulin-like growth factor levels and chronic lymphocytic leukaemia: results from the MCC-Spain and EpiLymph-Spain studies</dc:title>
   <dc:creator>Casabonne, Delphine</dc:creator>
   <dc:creator>Benavente, Yolanda</dc:creator>
   <dc:creator>Costas, Laura</dc:creator>
   <dc:creator>Robles Hellín, Claudia</dc:creator>
   <dc:creator>González Barca, Eva</dc:creator>
   <dc:creator>Banda, Esmeralda de la</dc:creator>
   <dc:creator>Alonso, Esther</dc:creator>
   <dc:creator>Aymerich Gregorio, Marta</dc:creator>
   <dc:creator>Campo Güerri, Elias</dc:creator>
   <dc:creator>Marcos-Gragera, Rafael</dc:creator>
   <dc:creator>García Tardón, Adonina</dc:creator>
   <dc:creator>Olmedo Requena, Rocío</dc:creator>
   <dc:creator>Gimeno Vázquez, Eva</dc:creator>
   <dc:creator>Martínez-López, Alba</dc:creator>
   <dc:creator>Casanovas i Casanovas, Oriol</dc:creator>
   <dc:creator>Castaño-Vinyals, Gemma</dc:creator>
   <dc:creator>Aragonés, Nuria</dc:creator>
   <dc:creator>Pollán, Marina</dc:creator>
   <dc:creator>Kogevinas, Manolis</dc:creator>
   <dc:creator>Sanjosé Llongueras, Silvia de</dc:creator>
   <dc:subject>Insulina -- Receptors</dc:subject>
   <dc:subject>Insulin -- Receptors</dc:subject>
   <dc:subject>Plasma sanguini</dc:subject>
   <dc:subject>Blood plasma</dc:subject>
   <dc:subject>Leucèmia limfocítica crònica</dc:subject>
   <dc:subject>Chronic lymphocytic leukemia</dc:subject>
   <dc:description>Insulin‐like growth factor levels and chronic lymphocytic leukaemia</dc:description>
   <dc:description>Spanish Ministry of Economy and Competitiveness–CarlosIII Institute of Health cofunded by FEDER funds/European Regional Develpment Fund (ERDF)–a way to build Europe (PI17/01280, PI11/01810, PI14/01219, PI11/02213, PI15/00966, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RD12/0036/0056, Rio Hortega CM13/00232, SV-09-CLINIC-1, CIBERESP and SAF2016-79347-R) and the Agència de Gestió d’Ajuts Universitaris i de Recerca AGAUR(2017SGR1085, 2014SGR756). The ICGC CLL-Genome Project was funded by Spanish Ministerio de Economía y Competitividad (MINECO) through the Instituto de Salud CarlosIII (ISCIII), PMP15/00007 and CIBERONC</dc:description>
   <dc:date>2019-05-01</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/acceptedVersion</dc:type>
   <dc:type>peer-reviewed</dc:type>
   <dc:identifier>http://hdl.handle.net/10256/18590</dc:identifier>
   <dc:identifier>http://hdl.handle.net/10256/18590</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1111/bjh.15583</dc:relation>
   <dc:relation>info:eu-repo/semantics/altIdentifier/issn/0007-1048</dc:relation>
   <dc:relation>info:eu-repo/semantics/altIdentifier/eissn/1365-2141</dc:relation>
   <dc:rights>Tots els drets reservats. This is the peer reviewed version of the following article: Casabonne D, Benavente Y, Costas L, Robles C, Gonzalez-Barca E, de la Banda E. et al. Insulin-like growth factor levels and chronic lymphocytic leukaemia: results from the MCC-Spain and EpiLymph-Spain studies. Br J Haematol. 2019 May;185(3):608-612, which has been published in final form at http://dx.doi.org/10.1111/bjh.15583. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Elsevier</dc:publisher>
   <dc:source>© British Journal of Haematology, 2019, vol. 185, núm. 3, p. 608-612</dc:source>
   <dc:source>Articles publicats (D-I)</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>